DiseaseID 25926

骨肉瘤

Osteogenic Sarcoma

Relationship Network

Interactive first-hop connections across herbs, ingredients, formulas, targets, diseases, symptoms, syndromes, evidence, and monographs.

Click a node to open it in a new tab

Disease: 1Symptom: 12Target: 12Links: 24

Arranging relationship network...

Record Fields

Scalar fields from the final disease record.

Disease Id: 25926
Core Entity Id: 118494
Source Entity Count: 1
Preferred Name: Osteogenic Sarcoma
Name Cn: 骨肉瘤
Name Pinyin: Gu Rou Liu
Name En: Osteogenic Sarcoma
Name Latin
Bilingual Status: complete
Disease Type
Umls Disease Type
Disgenet Type
Mesh Class
Do Class
Hpo Class
Mesh Class Name
Hpo Class Name
Do Class Name
Disease Definition: NCI2016_NICHD_1602D:A malignant neoplasm of connective tissue origin that produces bone or osteoid.|NCI2016_NCI-GLOSS_1602D:A cancer of the bone that usually affects the large bones of the arm or leg. It occurs most commonly in young people and affects more males than females.|NCI2016_CDISC_1602D:A malignant neoplasm usually arising from bone.|NCI2016_02D:A usually aggressive malignant bone-forming mesenchymal neoplasm, predominantly affecting adolescents and young adults. It usually involves bones and less frequently extraosseous sites. It often involves the long bones (particularly distal femur, proximal tibia, and proximal humerus). Pain with or without a palpable mass is the most frequent clinical symptom. It may spread to other anatomic sites, particularly the lungs.|MSH2017_2016_08_12:A sarcoma originating in bone-forming cells, affecting the ends of long bones. It is the most common and most malignant of sarcomas of the bones, and occurs chiefly among 10- to 25-year-old youths. (From Stedman, 25th ed)|HPO2016_07_04:A malignant bone tumor that usually develops during adolescence and usually affects the long bones including the tibia, femur, and humerus. The typical symptoms of osteosarcoma comprise bone pain, fracture, limitation of motion, and tenderness or swelling at the site of the tumor. [HPO:probinson]|CSP2006:malignant primary cancer of bone composed of a connective tissue stroma with evidence of malignant osteoid, bone and/or cartilage formation.
Version: v1,v2
Suppressed: No

Names

Preferred names, aliases, and source labels retained in the final schema.

Name

Osteogenic Sarcoma

Role

preferred

Source

SymMap_v2

Preferred

Yes

Cross References

Trusted external identifiers retained for this final record.

Umls

C0029463

Icd10

C41.9

Med Dra

10031291

Sym Map

SMDE01078

Orphanet

668

Attributes

Merged source attributes and domain-specific metadata.

Version

v1,v2

Suppress

Disease Definition

NCI2016_NICHD_1602D:A malignant neoplasm of connective tissue origin that produces bone or osteoid.|NCI2016_NCI-GLOSS_1602D:A cancer of the bone that usually affects the large bones of the arm or leg. It occurs most commonly in young people and affects more males than females.|NCI2016_CDISC_1602D:A malignant neoplasm usually arising from bone.|NCI2016_02D:A usually aggressive malignant bone-forming mesenchymal neoplasm, predominantly affecting adolescents and young adults. It usually involves bones and less frequently extraosseous sites. It often involves the long bones (particularly distal femur, proximal tibia, and proximal humerus). Pain with or without a palpable mass is the most frequent clinical symptom. It may spread to other anatomic sites, particularly the lungs.|MSH2017_2016_08_12:A sarcoma originating in bone-forming cells, affecting the ends of long bones. It is the most common and most malignant of sarcomas of the bones, and occurs chiefly among 10- to 25-year-old youths. (From Stedman, 25th ed)|HPO2016_07_04:A malignant bone tumor that usually develops during adolescence and usually affects the long bones including the tibia, femur, and humerus. The typical symptoms of osteosarcoma comprise bone pain, fracture, limitation of motion, and tenderness or swelling at the site of the tumor. [HPO:probinson]|CSP2006:malignant primary cancer of bone composed of a connective tissue stroma with evidence of malignant osteoid, bone and/or cartilage formation.